Kiora Pharmaceuticals Secures Grant for Vision Test Validation

InvestingApr 11 19:30

Kiora Pharmaceuticals Receives Grant From Choroideremia Research Foundation to Fund Novel Clinical Trial Endpoints for Inherited Retinal Diseases; Approval Granted to Initiate Clinical Validation Study

Encinitas, California--(Newsfile Corp. - April 11, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX) has received grant funding from the Choroideremia Research Foundation (CRF) in support of validati

newsfileApr 11 19:00

Kiora Pharmaceuticals to Present at Upcoming Investor Conferences

Yahoo FinanceApr 5 19:00

Analysts Offer Insights on Healthcare Companies: Altimmune (ALT), Kiora Pharmaceuticals (KPRX) and Actinium Pharmaceuticals (ATNM)

TipRanksMar 28 19:30

Kiora Pharmaceuticals to Present Additional Data From Its ABACUS-1 Trial in Retinitis Pigmentosa at the ARVO 2024 Annual Meeting

Encinitas, California--(Newsfile Corp. - March 28, 2024) - Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced that additional data from the ABACUS-1 trial has been accept

newsfileMar 28 18:45

Analysts Offer Insights on Healthcare Companies: Kiora Pharmaceuticals (KPRX) and Genmab (GMAB)

TipRanksMar 27 18:30